Research ArticleAtherosclerosis

Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis

See allHide authors and affiliations

Science Translational Medicine  06 Nov 2019:
Vol. 11, Issue 517, eaax0481
DOI: 10.1126/scitranslmed.aax0481

You are currently viewing the editor's summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Platelets and plaques

Platelet activation promotes inflammation, and macrophage-platelet aggregates have been found in cardiovascular disease. Barrett et al. investigated the role of platelets in regulating macrophage polarization in atherosclerosis. Mice with high cholesterol had increased platelet-macrophage aggregates in atherosclerotic plaques, and platelets promoted monocyte recruitment to plaques. Platelets enhanced macrophage expression of myeloid suppressor of cytokine signaling 3 (SOCS3), promoting a proinflammatory phenotype with impaired phagocytosis. Depleting platelets in mice reduced plaque size and macrophage accumulation. SOCS3 was up-regulated, and SOCS1:SOCS3 expression inversely correlated with platelet activity in patients with myocardial infarction and cardiovascular disease. Results elucidate an atherogenic role of platelets via regulation of myeloid inflammation.

View Full Text